{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T07:18:47Z","timestamp":1780816727776,"version":"3.54.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10846-z","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T07:40:48Z","timestamp":1753515648000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The association of RAGE gene polymorphisms with inflammatory and oxidative stress markers in diabetic kidney disease patients"],"prefix":"10.1007","volume":"52","author":[{"given":"Wijdan Abdullameer","family":"Kamel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Haghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid Tayebi","family":"Khosroshahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamreza","family":"Dehghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,26]]},"reference":[{"key":"10846_CR1","doi-asserted-by":"crossref","unstructured":"Twarda-Clapa A, Olczak A, Bia\u0142kowska AM, Kozio\u0142kiewicz M (2022) Advanced glycation end-products (AGEs): Formation, chemistry, classification, receptors, and diseases related to AGEs, Cells, vol. 11, no. 8, p. 1312","DOI":"10.3390\/cells11081312"},{"issue":"21","key":"10846_CR2","doi-asserted-by":"publisher","first-page":"14987","DOI":"10.1016\/S0021-9258(18)42137-0","volume":"267","author":"AM Schmidt","year":"1992","unstructured":"Schmidt AM et al (1992) Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J Biol Chem 267(21):14987\u201314997","journal-title":"J Biol Chem"},{"issue":"21","key":"10846_CR3","doi-asserted-by":"publisher","first-page":"14998","DOI":"10.1016\/S0021-9258(18)42138-2","volume":"267","author":"M Neeper","year":"1992","unstructured":"Neeper M et al (1992) Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267(21):14998\u201315004","journal-title":"J Biol Chem"},{"issue":"5","key":"10846_CR4","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.neurobiolaging.2009.04.016","volume":"32","author":"V Srikanth","year":"2011","unstructured":"Srikanth V, Maczurek A, Phan T, Steele M, Westcott B, Juskiw D, M\u00fcnch G (2011) Advanced glycation endproducts and their receptor RAGE in alzheimer\u2019s disease. Neurobiol Aging 32(5):763\u2013777","journal-title":"Neurobiol Aging"},{"issue":"2","key":"10846_CR5","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1159\/000488622","volume":"46","author":"M Rahimi","year":"2018","unstructured":"Rahimi M et al (2018) Soluble receptor for advanced glycation end products (sRAGE) is Up-regulated in multiple sclerosis patients treated with interferon \u03b2-1a. Cell Physiol Biochem 46(2):561\u2013567","journal-title":"Cell Physiol Biochem"},{"key":"10846_CR6","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3389\/fncel.2015.00485","volume":"9","author":"JK Juranek","year":"2015","unstructured":"Juranek JK, Daffu GK, Wojtkiewicz J, Lacomis D, Kofler J, Schmidt AM (2015) Receptor for advanced glycation end products and its inflammatory ligands are upregulated in amyotrophic lateral sclerosis. Front Cell Neurosci 9:485","journal-title":"Front Cell Neurosci"},{"key":"10846_CR7","doi-asserted-by":"crossref","unstructured":"Malik P, Chaudhry N, Mittal R, Mukherjee TK (2015) Role of receptor for advanced glycation end products in the complication and progression of various types of cancers, Biochimica et Biophysica Acta (BBA)-General Subjects, vol. 1850, no. 9, pp. 1898\u20131904","DOI":"10.1016\/j.bbagen.2015.05.020"},{"key":"10846_CR8","doi-asserted-by":"crossref","unstructured":"Basta G (2008) Receptor for advanced glycation endproducts and atherosclerosis: from basic mechanisms to clinical implications, Atherosclerosis, vol. 196, no. 1, pp. 9\u201321","DOI":"10.1016\/j.atherosclerosis.2007.07.025"},{"issue":"1","key":"10846_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0047-6374(01)00366-9","volume":"1","author":"DM Stern","year":"2002","unstructured":"Stern DM, Du Yan S, Yan SF, Schmidt AM (2002) Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes. Ageing Res Rev 1(1):1\u201315","journal-title":"Ageing Res Rev"},{"key":"10846_CR10","doi-asserted-by":"publisher","first-page":"1128872","DOI":"10.3389\/fphar.2023.1128872","volume":"14","author":"K Taguchi","year":"2023","unstructured":"Taguchi K, Fukami K (2023) RAGE signaling regulates the progression of diabetic complications. Front Pharmacol 14:1128872","journal-title":"Front Pharmacol"},{"issue":"9","key":"10846_CR11","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41574-022-00690-7","volume":"18","author":"D Tomic","year":"2022","unstructured":"Tomic D, Shaw JE, Magliano DJ (2022) The burden and risks of emerging complications of diabetes mellitus. Nat Reviews Endocrinol 18(9):525\u2013539","journal-title":"Nat Reviews Endocrinol"},{"key":"10846_CR12","unstructured":"Rauf CJ, Abdullameer W, Mohammed IA, Abass KS (2022) Estimation of blood minerals in people overusing sugar and in diabetic groups. Revista Latinoam De Hipertensi\u00f3n, 17, 5"},{"issue":"1","key":"10846_CR13","first-page":"49","volume":"5","author":"O Gheith","year":"2016","unstructured":"Gheith O, Farouk N, Nampoory N, Halim MA, Al-Otaibi T (2016) Diabetic kidney disease: worldwide difference of prevalence and risk factors. J Nephropharmacology 5(1):49","journal-title":"J Nephropharmacology"},{"issue":"12","key":"10846_CR14","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/CJN.11491116","volume":"12","author":"RZ Alicic","year":"2017","unstructured":"Alicic RZ, Rooney MT, Tuttle KR (2017) Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol 12(12):2032\u20132045","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10846_CR15","first-page":"1","volume":"1","author":"MC Thomas","year":"2015","unstructured":"Thomas MC et al (2015) Diabetic kidney disease. Nat Reviews Disease Primers 1(1):1\u201320","journal-title":"Nat Reviews Disease Primers"},{"key":"10846_CR16","doi-asserted-by":"crossref","unstructured":"Chen Y, Lee K, Ni Z, He JC (2020) Diabetic kidney disease: challenges, advances, and opportunities, Kidney diseases, vol. 6, no. 4, pp. 215\u2013225","DOI":"10.1159\/000506634"},{"key":"10846_CR17","doi-asserted-by":"crossref","unstructured":"Mima A (2013) Inflammation and oxidative stress in diabetic nephropathy: new insights on its inhibition as new therapeutic targets, Journal of Diabetes Research, vol. no. 1, p. 248563, 2013","DOI":"10.1155\/2013\/248563"},{"key":"10846_CR18","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.freeradbiomed.2021.05.025","volume":"171","author":"X-Q Wu","year":"2021","unstructured":"Wu X-Q, Zhang D-D, Wang Y-N, Tan Y-Q, Yu X-Y, Zhao Y-Y (2021) AGE\/RAGE in diabetic kidney disease and ageing kidney. Free Radic Biol Med 171:260\u2013271","journal-title":"Free Radic Biol Med"},{"issue":"7","key":"10846_CR19","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.3390\/ijms23073439","volume":"23","author":"M Steenbeke","year":"2022","unstructured":"Steenbeke M, Speeckaert R, Desmedt S, Glorieux G, Delanghe JR, Speeckaert MM (2022) The role of advanced glycation end products and its soluble receptor in kidney diseases. Int J Mol Sci 23(7):3439","journal-title":"Int J Mol Sci"},{"key":"10846_CR20","doi-asserted-by":"crossref","unstructured":"Hudson BI, Stickland MH, Futers TS, Grant PJ (2001) Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy, Diabetes, vol. 50, no. 6, pp. 1505\u20131511","DOI":"10.2337\/diabetes.50.6.1505"},{"key":"10846_CR21","doi-asserted-by":"crossref","unstructured":"Kang P, Tian C, Jia C (2012) Association of RAGE gene polymorphisms with type 2 diabetes mellitus, diabetic retinopathy and diabetic nephropathy, Gene, vol. 500, no. 1, pp. 1\u20139","DOI":"10.1016\/j.gene.2012.03.056"},{"key":"10846_CR22","doi-asserted-by":"publisher","first-page":"105529","DOI":"10.1016\/j.archoralbio.2022.105529","volume":"143","author":"ANA Silva","year":"2022","unstructured":"Silva ANA et al (2022) Polymorphisms in risk genes of type 2 diabetes mellitus could be also markers of susceptibility to periodontitis. Arch Oral Biol 143:105529","journal-title":"Arch Oral Biol"},{"issue":"10","key":"10846_CR23","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1093\/ndt\/gfw263","volume":"32","author":"SC Lim","year":"2017","unstructured":"Lim SC et al (2017) Genetic variants in the receptor for advanced glycation end products (RAGE) gene were associated with Circulating soluble RAGE level but not with renal function among Asians with type 2 diabetes: a genome-wide association study. Nephrol Dialysis Transplantation 32(10):1697\u20131704","journal-title":"Nephrol Dialysis Transplantation"},{"key":"10846_CR24","doi-asserted-by":"crossref","unstructured":"Cai W et al (2015) Association of 2184AG polymorphism in the RAGE gene with diabetic nephropathy in Chinese patients with type 2 diabetes, Journal of Diabetes Research, vol. no. 1, p. 310237, 2015","DOI":"10.1155\/2015\/310237"},{"issue":"6","key":"10846_CR25","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1093\/ndt\/gfh711","volume":"20","author":"K Kankov\u00e1","year":"2005","unstructured":"Kankov\u00e1 K, Stejskalova A, Hertlov\u00e1 M, Znojil V (2005) Haplotype analysis of the RAGE gene: identification of a haplotype marker for diabetic nephropathy in type 2 diabetes mellitus. Nephrol Dialysis Transplantation 20(6):1093\u20131102","journal-title":"Nephrol Dialysis Transplantation"},{"key":"10846_CR26","doi-asserted-by":"crossref","unstructured":"Zhang Y et al (2017) Association of single-nucleotide polymorphisms in the RAGE gene and its gene-environment interactions with diabetic nephropathy in Chinese patients with type 2 diabetes, Oncotarget, vol. 8, no. 57, p. 96885","DOI":"10.18632\/oncotarget.18785"},{"key":"10846_CR27","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1007\/s00125-006-0412-3","volume":"49","author":"E Lindholm","year":"2006","unstructured":"Lindholm E, Bakhtadze E, Sj\u00f6gren M, Cilio C, Agardh E, Groop L, Agardh C.-D. (2006) The\u2013\u2009374 T\/A polymorphism in the gene encoding RAGE is associated with diabetic nephropathy and retinopathy in type 1 diabetic patients. Diabetologia 49:2745\u20132755","journal-title":"Diabetologia"},{"issue":"6","key":"10846_CR28","doi-asserted-by":"publisher","first-page":"e2546","DOI":"10.1371\/journal.pone.0002546","volume":"3","author":"E Lindholm","year":"2008","unstructured":"Lindholm E, Bakhtadze E, Cilio C, Agardh E, Groop L, Agardh C-D (2008) Association between LTA, TNF and AGER polymorphisms and late diabetic complications. PLoS ONE 3(6):e2546","journal-title":"PLoS ONE"},{"key":"10846_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2350-11-52","volume":"11","author":"P Prasad","year":"2010","unstructured":"Prasad P, Tiwari AK, Kumar KP, Ammini A, Gupta A, Gupta R, Thelma B (2010) Association analysis of ADPRT1, AKR1B1, RAGE, GFPT2 and PAI-1 gene polymorphisms with chronic renal insufficiency among Asian Indians with type-2 diabetes. BMC Med Genet 11:1\u20138","journal-title":"BMC Med Genet"},{"key":"10846_CR30","doi-asserted-by":"crossref","unstructured":"Hauser E, Cremer N, Hein R, Deshmukh H (2009) Haplotype-based analysis: a summary of GAW16 Group 4 analysis, Genetic epidemiology, vol. 33, no. S1, pp. S24-S28","DOI":"10.1002\/gepi.20468"},{"key":"10846_CR31","doi-asserted-by":"crossref","unstructured":"Wong FN, Chua KH, Kuppusamy UR, Wong CM, Lim SK, Tan JAMA (1908) Association of the receptor for advanced glycation end-products (RAGE) gene polymorphisms in Malaysian patients with chronic kidney disease, PeerJ, vol. 4, p. e 2016","DOI":"10.7717\/peerj.1908"},{"key":"10846_CR32","unstructured":"Tavakoli A, Salahshourifar I, Hajialilo E, Haghdoost-Yazdi H, Ilghari D, Piri H (2022) Haplotype analysis of RAGE gene polymorphisms and association with increased risk of diabetic nephropathy. J Kerman Univ Med Sci, 29, 1"},{"issue":"10","key":"10846_CR33","first-page":"ZC58","volume":"10","author":"D Pandya","year":"2016","unstructured":"Pandya D, Nagrajappa AK, Ravi K (2016) Assessment and correlation of Urea and creatinine levels in saliva and serum of patients with chronic kidney disease, diabetes and hypertension\u2013a research study. J Clin Diagn Research: JCDR 10(10):ZC58","journal-title":"J Clin Diagn Research: JCDR"},{"issue":"2","key":"10846_CR34","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.diabres.2010.11.016","volume":"91","author":"W Hu","year":"2011","unstructured":"Hu W, Feng P (2011) Elevated serum chemerin concentrations are associated with renal dysfunction in type 2 diabetic patients. Diabetes Res Clin Pract 91(2):159\u2013163","journal-title":"Diabetes Res Clin Pract"},{"key":"10846_CR35","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s10059-010-0109-9","volume":"30","author":"T Araoka","year":"2010","unstructured":"Araoka T et al (2010) Transcription factor 7-like 2 (TCF7L2) regulates activin receptor-like kinase 1 (ALK1)\/Smad1 pathway for development of diabetic nephropathy. Mol Cells 30:209\u2013218","journal-title":"Mol Cells"},{"issue":"10","key":"10846_CR36","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.3390\/jcm12103366","volume":"12","author":"NL Reynaert","year":"2023","unstructured":"Reynaert NL, Vanfleteren LE, Perkins TN (2023) The AGE-RAGE Axis and the pathophysiology of Multimorbidity in COPD. J Clin Med 12(10):3366","journal-title":"J Clin Med"},{"key":"10846_CR37","doi-asserted-by":"crossref","unstructured":"Ziyadeh FN (2004) Mediators of diabetic renal disease: the case for TGF-\u03b2 as the major mediator, Journal of the American Society of Nephrology, vol. 15, no. 1_suppl, pp. S55-S57","DOI":"10.1097\/01.ASN.0000093460.24823.5B"},{"key":"10846_CR38","doi-asserted-by":"crossref","unstructured":"Nakamura T, Fukui M, Ebihara I, Osada S, Nagaoka I, Tomino Y, Koide H (1993) mRNA expression of growth factors in glomeruli from diabetic rats, Diabetes, vol. 42, no. 3, pp. 450\u2013456","DOI":"10.2337\/diabetes.42.3.450"},{"key":"10846_CR39","doi-asserted-by":"publisher","first-page":"BMI","DOI":"10.4137\/BMI.S38440","volume":"11","author":"SI Sherwani","year":"2016","unstructured":"Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK (2016) Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomark Insights 11:BMI","journal-title":"Biomark Insights"},{"key":"10846_CR40","doi-asserted-by":"crossref","unstructured":"Molitch ME et al (2015) Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes, Kidney international, vol. 87, no. 1, pp. 20\u201330","DOI":"10.1038\/ki.2014.128"},{"issue":"9","key":"10846_CR41","doi-asserted-by":"publisher","first-page":"e0184789","DOI":"10.1371\/journal.pone.0184789","volume":"12","author":"R Yacoub","year":"2017","unstructured":"Yacoub R et al (2017) Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial. PLoS ONE 12(9):e0184789","journal-title":"PLoS ONE"},{"key":"10846_CR42","doi-asserted-by":"crossref","unstructured":"Huang K-P, Chen C, Hao J, Huang J-Y, Liu P-Q, Huang H-Q (2015) AGEs-RAGE system down-regulates Sirt1 through the ubiquitin-proteasome pathway to promote FN and TGF-\u03b21 expression in male rat glomerular mesangial cells, Endocrinology, vol. 156, no. 1, pp. 268\u2013279","DOI":"10.1210\/en.2014-1381"},{"key":"10846_CR43","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1515\/bmc-2016-0021","volume":"7","author":"A Kumar Pasupulati","year":"2016","unstructured":"Kumar Pasupulati A, Chitra PS, Reddy GB (2016) Advanced glycation end products mediated cellular and molecular events in the pathology of diabetic nephropathy. Biomol Concepts 7:5\u20136","journal-title":"Biomol Concepts"},{"issue":"9","key":"10846_CR44","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/labinvest.3700445","volume":"86","author":"A Mima","year":"2006","unstructured":"Mima A et al (2006) Angiotensin II-dependent Src and Smad1 signaling pathway is crucial for the development of diabetic nephropathy. Lab Invest 86(9):927\u2013939","journal-title":"Lab Invest"},{"issue":"8","key":"10846_CR45","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/ki.2010.526","volume":"79","author":"A Mima","year":"2011","unstructured":"Mima A et al (2011) Glomerular-specific protein kinase C-\u03b2-induced insulin receptor substrate-1 dysfunction and insulin resistance in rat models of diabetes and obesity. Kidney Int 79(8):883\u2013896","journal-title":"Kidney Int"},{"key":"10846_CR46","doi-asserted-by":"crossref","unstructured":"Mima A et al (2012) Protective effects of GLP-1 on glomerular endothelium and its inhibition by PKC\u03b2 activation in diabetes, Diabetes, vol. 61, no. 11, pp. 2967\u20132979","DOI":"10.2337\/db11-1824"},{"key":"10846_CR47","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.lfs.2018.08.067","volume":"210","author":"V Ravarotto","year":"2018","unstructured":"Ravarotto V, Simioni F, Pagnin E, Davis PA, Cal\u00f2 LA (2018) Oxidative stress\u2013chronic kidney disease\u2013cardiovascular disease: A vicious circle. Life Sci 210:125\u2013131","journal-title":"Life Sci"},{"issue":"3","key":"10846_CR48","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1089\/ars.2016.6665","volume":"25","author":"BB Ratliff","year":"2016","unstructured":"Ratliff BB, Abdulmahdi W, Pawar R, Wolin MS (2016) Oxidant mechanisms in renal injury and disease. Antioxid Redox Signal 25(3):119\u2013146","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"10846_CR49","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1152\/physrev.00040.2012","volume":"94","author":"A Bhattacharyya","year":"2014","unstructured":"Bhattacharyya A, Chattopadhyay R, Mitra S, Crowe SE (2014) Oxidative stress: an essential factor in the pathogenesis of Gastrointestinal mucosal diseases. Physiol Rev 94(2):329\u2013354","journal-title":"Physiol Rev"},{"issue":"1","key":"10846_CR50","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1152\/physrev.00045.2011","volume":"93","author":"JM Forbes","year":"2013","unstructured":"Forbes JM, Cooper ME (2013) Mechanisms of diabetic complications. Physiol Rev 93(1):137\u2013188","journal-title":"Physiol Rev"},{"key":"10846_CR51","doi-asserted-by":"crossref","unstructured":"Hodgkinson AD, Bartlett T, Oates PJ, Millward BA, Demaine AG (2003) The response of antioxidant genes to hyperglycemia is abnormal in patients with type 1 diabetes and diabetic nephropathy, Diabetes, vol. 52, no. 3, pp. 846\u2013851","DOI":"10.2337\/diabetes.52.3.846"},{"key":"10846_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2009.06.028","volume":"407","author":"K Takemoto","year":"2009","unstructured":"Takemoto K et al (2009) Low catalase activity in blood is associated with the diabetes caused by Alloxan. Clin Chim Acta 407:1\u20132","journal-title":"Clin Chim Acta"},{"issue":"3","key":"10846_CR53","first-page":"118","volume":"12","author":"M Zarei","year":"2016","unstructured":"Zarei M et al (2016) Lipid peroxidation and antioxidant enzymes activity in controlled and uncontrolled type 2 diabetic patients. ARYA Atherosclerosis 12(3):118","journal-title":"ARYA Atherosclerosis"},{"key":"10846_CR54","doi-asserted-by":"publisher","first-page":"628289","DOI":"10.3389\/fmed.2020.628289","volume":"7","author":"J Donate-Correa","year":"2021","unstructured":"Donate-Correa J et al (2021) Inflammatory cytokines in diabetic kidney disease: pathophysiologic and therapeutic implications. Front Med 7:628289","journal-title":"Front Med"},{"issue":"4","key":"10846_CR55","doi-asserted-by":"publisher","first-page":"180","DOI":"10.4103\/1947-2714.94944","volume":"4","author":"R Goyal","year":"2012","unstructured":"Goyal R, Faizy AF, Siddiqui SS, Singhai M (2012) Evaluation of TNF-\u03b1 and IL-6 levels in obese and non-obese diabetics: pre-and postinsulin effects. North Am J Med Sci 4(4):180","journal-title":"North Am J Med Sci"},{"issue":"11","key":"10846_CR56","doi-asserted-by":"publisher","first-page":"3798","DOI":"10.3390\/ijms21113798","volume":"21","author":"S Rayego-Mateos","year":"2020","unstructured":"Rayego-Mateos S et al (2020) Pathogenic pathways and therapeutic approaches targeting inflammation in diabetic nephropathy. Int J Mol Sci 21(11):3798","journal-title":"Int J Mol Sci"},{"key":"10846_CR57","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fendo.2013.00007","volume":"4","author":"K Kanasaki","year":"2013","unstructured":"Kanasaki K, Taduri G, Koya D (2013) Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis. Front Endocrinol 4:7","journal-title":"Front Endocrinol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10846-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10846-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10846-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T04:27:59Z","timestamp":1766896079000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10846-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10846"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10846-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,26]]},"assertion":[{"value":"4 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"759"}}